IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — SCYX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents10.4936.6714.8011.026.9428.7325.9935.4844.0757.9126.9168.62118.6995.21100.11112.4592.01
Short-term Investments43.6022.5923.1333.7733.6740.1047.0444.7644.0027.6427.9127.47----------
Accounts Receivable----------------2.252.352.062.492.211.630.03----
Inventory----------------13.1110.291.110.790.631.150.630.09--
Total Current Assets56.2462.6948.6956.5052.2280.4694.58101.67128.64145.5359.77103.57125.68101.91103.93115.6395.38
Property, Plant & Equipment--------------------------0.060.170.220.27
Intangible Assets----------------0.100.210.310.770.870.961.150.570.38
Total Non-current Assets*18.7314.942.384.2015.6918.5813.2316.5819.919.3310.538.739.949.665.955.504.70
Total Assets74.9777.6351.0760.6967.9299.04107.81118.25148.55154.8670.30112.29135.61111.56109.88121.13100.07
Accounts Payable3.275.633.476.174.264.965.358.923.493.425.937.429.968.137.515.956.52
Total Current Liabilities5.8315.908.4710.868.9625.7225.2327.3516.7916.1645.6414.2616.0112.9413.2219.8824.93
Long-term Debt--------------------34.6534.1633.9433.7128.5828.38--
Total Non-current Liabilities*2.2220.426.175.368.4314.7922.1716.8039.7745.6254.5780.8274.1259.6959.0568.9349.22
Total Liabilities8.0436.3214.6416.2317.3840.5147.4044.1556.5661.78100.2195.0890.1372.6472.2788.8174.15
Retained Earnings(399.05)(406.44)(397.40)(388.81)(381.93)(372.10)(369.29)(354.84)(335.66)(333.90)(456.16)(407.86)(378.27)(364.93)(330.24)(329.63)(331.29)
Total Stockholder Equity66.9341.3136.4344.4750.5358.5360.4174.1191.9993.08(29.91)17.2145.4838.9337.6132.3225.92

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.240.0018.650.331.360.260.980.660.741.375.801.76131.451.131.521.561.320.690.600.52
Research & Development3.8912.354.555.457.145.144.318.076.817.2110.596.477.046.847.966.437.135.747.694.40
Selling, General & Admin4.124.593.603.293.783.734.722.913.173.673.595.017.474.8415.8516.7415.7914.5915.0415.41
Total Operating Expenses8.0116.948.148.7410.938.879.0310.989.9710.8828.8611.8614.9411.8124.0023.3623.0620.4322.8919.96
Operating Income(7.77)(16.94)10.50(8.40)(9.56)(8.61)(8.05)(10.32)(9.24)(9.51)(23.06)(10.10)116.51(10.68)(22.48)(21.80)(21.74)(19.74)(22.29)(19.44)
Interest Expense----------------0.200.210.220.211.251.451.531.381.231.060.981.02
Pretax Income----12.26(8.59)(6.88)(5.39)(4.42)(3.20)(14.46)0.94(19.45)(1.76)122.26(33.88)(14.43)(29.58)(13.34)(10.15)(29.24)(0.65)
Tax Provision----0.000.000.000.000.02(0.39)0.000.530.140.000.000.000.000.000.00(4.70)0.00(0.05)
Net Income7.40(21.30)12.26(8.59)(6.88)(5.39)(4.43)(2.81)(14.46)0.41(19.59)(1.76)122.26(33.88)(14.43)(29.58)(13.34)(5.45)(29.24)(0.60)
Basic EPS0.63(0.42)0.25(0.17)(0.14)(0.11)(0.09)(0.06)(0.30)0.01(0.41)(0.04)2.56(0.71)(0.37)(0.62)(0.31)(0.17)--(0.02)
Diluted EPS0.63(0.42)0.25(0.17)(0.14)(0.11)(0.09)(0.06)(0.30)0.01(0.32)(0.04)2.46(0.71)(0.36)(0.62)(0.31)(0.18)--(0.06)

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(14.88)(8.10)18.40(8.72)(7.49)(7.46)(9.91)0.77(10.86)(4.01)(7.73)12.4274.40(18.92)(22.81)(22.51)(18.58)(15.99)(25.52)(16.59)
Capital Expenditures------------------------------------0.000.00
Free Cash Flow*------------------------------------(25.52)(16.59)
Investing Cash Flow(24.76)(0.52)(11.82)12.4211.2712.44(2.62)1.941.375.45(2.15)(26.34)(6.38)0.000.00(27.38)0.00(0.01)(0.58)(0.34)
Financing Cash Flow13.4624.04(0.11)0.030.00(14.08)(0.15)0.030.00(0.01)(0.13)0.03(36.64)0.020.00(0.18)42.066.7230.484.53

* Derived from reported values